Explore

TrendlineTrendline
Dermatologists Advocate for Topical Peptide Serums Over Unapproved Injections for Skincare Benefits

Dermatologists Advocate for Topical Peptide Serums Over Unapproved Injections for Skincare Benefits

Dermatologists Advocate for Topical Peptide Serums Over Unapproved Injections for Skincare Benefits
Rapid ReadRapid Read
Texas A Research Highlights Creatine's Role in Muscle Preservation and Strength for Older Adults

Texas A Research Highlights Creatine's Role in Muscle Preservation and Strength for Older Adults

New research from Texas A&M University indicates that creatine offers significant benefits for muscle preservation and strength, particularly in older adults. A 12-week study, published in the Journal of the International Society of Sports Nutrition, involved adults aged 45–65. The findings showed that participants who took creatine gained lean tissue and improved their leg and bench press strength, even without engaging in a structured exercise program. Those who combined creatine supplementation with exercise experienced even greater gains. Dr. Richard Kreider, professor and director of the Exercise and Sport Nutrition Lab at Texas A&M and the study's principal investigator, has been studying creatine for over 30 years. His research consistently points to creatine's role in replenishing cellular energy and its positive effects on exercise performance, muscle, and strength across the lifespan. The study also observed that participants taking creatine had a greater reduction in body fat percentage when com...
Rapid ReadRapid Read
FDA Modernizes Dietary Ingredient Definition, Signaling Stricter Enforcement and Innovation in Food Technology

FDA Modernizes Dietary Ingredient Definition, Signaling Stricter Enforcement and Innovation in Food Technology

The U.S. Food and Drug Administration (FDA) is actively working to modernize its definition of dietary ingredients, particularly in response to advancements in food technology such as precision fermentation and cell culture technology. This initiative is part of a broader push by the FDA's Human Foods Program (HFP) to enhance enforcement and update regulations within the food and supplement industries. The agency's placement of dietary supplements under the Office of Food Chemical Safety, Dietary Supplements & Innovation indicates a strategic shift, framing supplements as a 'risk pillar' rather than a niche category. This signals a serious intent for stronger enforcement and modernization across the board. Concurrently, state-level regulations are emerging, creating a fragmented compliance landscape as states address perceived gaps in federal oversight. The FDA is also considering closing the Generally Recognized as Safe (GRAS) loophole, which currently allows companies to self-affirm GRAS status without a...
TheStreetTheStreet
Kroger shoppers stopped trusting one key part of the store

Kroger shoppers stopped trusting one key part of the store

Nearly every American shops in this aisle, and the damage is not staying there.
Rapid ReadRapid Read
Rep. John Carter Supports Bipartisan ASAP Act for Medicare Coverage of Alzheimer's Blood Tests

Rep. John Carter Supports Bipartisan ASAP Act for Medicare Coverage of Alzheimer's Blood Tests

Rep. John Carter is advocating for the bipartisan Alzheimer’s Screening and Prevention (ASAP) Act, which aims to enable Medicare coverage for FDA-approved blood tests designed to detect Alzheimer’s biomarkers. Currently, Medicare regulations prohibit coverage for any dementia screening test for individuals without symptoms, creating a significant barrier to early detection. The ASAP Act seeks to rectify this legal impediment, offering a more scalable and accessible diagnostic approach compared to previous methods. This legislative effort is highlighted by Stephenie Evans, a former caregiver from Belton, Texas, who emphasizes the critical difference early detection can make for families affected by Alzheimer's. Her personal experience with her grandmother, who lived with Alzheimer's for a decade, underscores the potential for earlier diagnoses to improve quality of life and allow families more time to prepare for the future. The initiative aligns with global efforts to raise awareness and challenge the stig...
TrendlineTrendline
Dr. Scholl's Launches Pin Point Skin Tag Remover Utilizing Professional-Grade Cryotherapy for At-Home Use

Dr. Scholl's Launches Pin Point Skin Tag Remover Utilizing Professional-Grade Cryotherapy for At-Home Use

Dr. Scholl's Launches Pin Point Skin Tag Remover Utilizing Professional-Grade Cryotherapy for At-Home Use
ReutersReuters
US regulators examine testosterone therapy for women as experts debate evidence, safety

US regulators examine testosterone therapy for women as experts debate evidence, safety

By Siddhi Mahatole and Padmanabhan Ananthan Sept 17 (Reuters) - US health regulators weighing testosterone use in menopausal women at a public meeting on Thursday were told by some experts that a female-specific product was needed while others pointed to gaps in evidence on the hormone's broader
ReutersReuters
US regulators urge more research on testosterone therapy for women as experts debate benefits, risks

US regulators urge more research on testosterone therapy for women as experts debate benefits, risks

By Siddhi Mahatole and Padmanabhan Ananthan Sept 17 (Reuters) - US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support future approvals of female-specific products.
ReutersReuters
Experts urge FDA to set clear safety and access standards for psychedelic drugs (September 14)

Experts urge FDA to set clear safety and access standards for psychedelic drugs (September 14)

(Corrects quote attribution in paragraph 8 of September 14 story from Lynn Watkins, a U.S.
Rapid ReadRapid Read
UNC Eshelman School of Pharmacy Researcher Develops Potential Chikungunya Treatments Amid Rising U.S. Cases

UNC Eshelman School of Pharmacy Researcher Develops Potential Chikungunya Treatments Amid Rising U.S. Cases

Anwar Hossain, a research assistant professor at the UNC Eshelman School of Pharmacy, is developing potential treatments for the mosquito-borne chikungunya virus. This initiative comes as the U.S. has reported over 100 travel-related cases of the virus this year. Hossain, a medicinal chemist, is advancing two promising compounds discovered through a federally funded center, part of the Rapidly Emerging Antiviral Drug Development Initiative (READDI) based at UNC-Chapel Hill. His work involves redesigning these compounds at a molecular level to enhance their potency against chikungunya and related viruses, with the ultimate goal of gaining Food and Drug Administration approval. The Translational Academy at Eshelman Innovation is supporting Hossain, providing funding and entrepreneurial training to help transition his lab discoveries into viable treatments. This support enabled his promotion from postdoctoral researcher and secured critical seed funds for his research.
The Columbus DispatchThe Columbus Dispatch
CDC declares cyclosporiasis outbreak over, new Ohio cases drop significantly

CDC declares cyclosporiasis outbreak over, new Ohio cases drop significantly

U.S. health officials have declared the largest known outbreak of cyclosporiasis is over as new cases in Ohio drop dramatically over the past week.
ReutersReuters
Ultragenyx sets $3.95 million price for rare disease gene therapy

Ultragenyx sets $3.95 million price for rare disease gene therapy

By Sriparna Roy and Kamal Choudhury Sept 17 (Reuters) - Ultragenyx Pharmaceutical said on Thursday it has set a U.S. list price of $3.95 million for its newly approved gene therapy Fayuvi, launching one of the world's most expensive drugs as a one-time treatment for a rare, fatal childhood disease.